Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?

ABSTRACT:

Objectives

To assess the visibility of clinically significant prostate cancer (PCA) lesions on the sequences multiparametric MRI of the prostate (mpMRI) and to evaluate whether the addition of dynamic contrast-enhanced imaging (DCE) improves the overall visibility.

Methods

We retrospectively evaluated multiparametric MRI images of 119 lesions in 111 patients with biopsy-proven clinically significant PCA. Three readers assigned visual grading scores for visibility on each sequence, and a visual grading characteristic analysis was performed. Linear regression was used to explore which factors contributed to visibility in individual sequences.

Results

The visibility of lesions was significantly better with mpMRI when compared to biparametric MRI in visual grading charact

SUBMITTER: Huebner NA 

PROVIDER: S-EPMC8128749 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature